Sfoglia per Rivista DIABETES, OBESITY AND METABOLISM
Impact of baseline kidney function on the effects of sodium-glucose co-transporter-2 inhibitors on kidney and heart failure outcomes: A systematic review and meta-analysis of randomized controlled trials
2023-01-01 Maddaloni, Ernesto; Cavallari, Ilaria; La Porta, Ylenia; Appetecchia, Alessandro; D'Onofrio, Luca; Grigioni, Francesco; Buzzetti, Raffaella; Holman, Rury R
Impact of obesity on the increasing incidence of type 1 diabetes.
2020-01-01 Buzzetti, R; Zampetti, S; Pozzilli, P
Long-term risk of cardiovascular disease in individuals with latent autoimmune diabetes in adults (UKPDS 85)
2019-01-01 Maddaloni, E.; Coleman, R. L.; Pozzilli, P; Holman, R. R.
Placebo-controlled, randomized trial of the addition of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide to titrated daily insulin glargine in patients with type 2 diabetes (AWARD-9).
2017-01-01 Pozzilli, P; Norwood, P; Jódar, E; Davies, Mj; Ivanyi, T; Jiang, H; Woodward, Db; Milicevic, Z
Review of clinical trials: update on oral insulin spray formulation
2010-01-01 Pozzilli, P; Raskin, P; Parkin, Cg
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile